CELL CYCLE

Scope & Guideline

Pioneering Discoveries for Tomorrow's Biological Challenges.

Introduction

Immerse yourself in the scholarly insights of CELL CYCLE with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1538-4101
PublisherTAYLOR & FRANCIS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2002 to 2024
AbbreviationCELL CYCLE / Cell Cycle
Frequency24 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The journal 'CELL CYCLE' primarily focuses on the intricate mechanisms governing cell proliferation, division, and apoptosis, exploring their implications in cancer biology and therapeutic interventions. The journal aims to bridge basic and clinical research, highlighting novel findings that elucidate the molecular pathways involved in cell cycle regulation and related cellular processes.
  1. Cell Cycle Regulation and Mechanisms:
    Research articles frequently explore various aspects of cell cycle control, including the roles of cyclins, cyclin-dependent kinases (CDKs), and checkpoint proteins in normal and cancerous cells.
  2. Molecular Mechanisms in Cancer:
    The journal emphasizes studies that investigate the molecular underpinnings of cancer progression, metastasis, and resistance to therapies, often focusing on key signaling pathways and regulatory networks.
  3. Role of Non-Coding RNAs:
    There is a significant emphasis on the functions of long non-coding RNAs (lncRNAs) and microRNAs in regulating gene expression related to cell proliferation, differentiation, and apoptosis in various cancer types.
  4. Therapeutic Strategies and Drug Resistance:
    Papers often discuss novel therapeutic approaches, including targeted therapies and the mechanisms of drug resistance, highlighting the significance of understanding cellular responses to treatments.
  5. Cellular Stress Responses and Aging:
    Research on cellular responses to stress, senescence, and their implications in aging and age-related diseases are also core areas of focus.
Recent publications in 'CELL CYCLE' reveal emerging trends that highlight the evolving landscape of cell cycle research, particularly in the context of cancer and therapeutic development. These trends reflect a growing interest in molecular complexity and the interplay between various cellular mechanisms.
  1. Integrative Omics Approaches:
    The use of multi-omics strategies, including genomics, transcriptomics, and proteomics, is gaining traction, providing comprehensive insights into the regulation of cell cycle processes and cancer biology.
  2. Microenvironmental Influences on Cell Cycle:
    There is an increasing focus on how tumor microenvironments affect cell cycle regulation, including the role of stromal interactions and extracellular matrix components in tumor progression.
  3. CircRNA Research:
    The investigation of circular RNAs (circRNAs) as regulatory molecules in the cell cycle and cancer has emerged as a significant theme, with studies exploring their potential as biomarkers and therapeutic targets.
  4. Targeted Therapy and Immunotherapy:
    Research on targeted therapies and immunotherapies is expanding, particularly studies that elucidate how cell cycle regulation affects treatment responses and resistance mechanisms.
  5. Cellular Senescence and Aging:
    An increasing number of articles focus on the role of cellular senescence in cancer biology and aging, exploring how senescence influences tumorigenesis and response to therapy.

Declining or Waning

Over recent years, certain themes within 'CELL CYCLE' have seen a noticeable decrease in prominence. This waning interest may reflect shifting research priorities or advancements in technology that allow for more nuanced exploration of previously established topics.
  1. Basic Cell Cycle Studies:
    There has been a decline in publications focusing solely on fundamental aspects of the cell cycle without direct implications for cancer or therapeutic intervention, as more studies aim for translational relevance.
  2. Traditional Cancer Biomarkers:
    Research centered solely on established cancer biomarkers is decreasing, with a shift toward identifying novel markers and understanding their functional roles within complex regulatory networks.
  3. In vitro Models:
    There is a marked reduction in studies employing basic in vitro models for cell cycle research, as the field increasingly favors more sophisticated in vivo and multi-dimensional models that better mimic the tumor microenvironment.
  4. Single Pathway Analysis:
    The trend has shifted away from isolated studies of single signaling pathways, with more research focusing on integrative approaches that consider multiple pathways and their interactions.

Similar Journals

CELLULAR AND MOLECULAR BIOLOGY

Exploring the Intricacies of Cellular Mechanisms
Publisher: C M B ASSOCISSN: 0145-5680Frequency: 8 issues/year

Cellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.

DNA AND CELL BIOLOGY

Fostering Innovation in Biological Research
Publisher: MARY ANN LIEBERT, INCISSN: 1044-5498Frequency: 12 issues/year

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.

NATURE REVIEWS MOLECULAR CELL BIOLOGY

Pioneering knowledge synthesis in molecular and cellular biology.
Publisher: NATURE PORTFOLIOISSN: 1471-0072Frequency: 12 issues/year

NATURE REVIEWS MOLECULAR CELL BIOLOGY, published by NATURE PORTFOLIO, stands as a seminal journal in the fields of cell and molecular biology, with a significant impact factor that underscores its influence and reputation within the scientific community. Established in 2000 and continuing its legacy into 2024, this journal delivers comprehensive reviews that synthesize current knowledge and advancements in molecular and cellular processes. Respected for its high-quality articles, it has maintained a prestigious Q1 ranking in both Cell Biology and Molecular Biology categories as of 2023. With an exceptional Scopus ranking, taking the top position in its category, it attracts a readership of prominent researchers, professionals, and students eager to stay abreast of groundbreaking discoveries and methodologies. Although it does not offer Open Access, subscribers benefit from exclusive access to vital insights that foster innovative research approaches and advancements in the life sciences. The journal’s objective is to bridge the gap between research and application, providing indispensable resources to its audience while contributing to the global conversation on molecular and cellular biology.

JOURNAL OF CELLULAR BIOCHEMISTRY

Pioneering Innovative Discoveries in Cellular Biology
Publisher: WILEYISSN: 0730-2312Frequency: 12 issues/year

Journal of Cellular Biochemistry is a premier academic journal dedicated to advancing the field of biochemistry and cellular biology. Published by Wiley, this influential journal has a significant impact factor that underscores its relevance and authority within the scientific community. With its ISSN 0730-2312 and E-ISSN 1097-4644, the journal has been on the frontier of research since its inception in 1982, and is expected to continue publishing cutting-edge studies through 2024. As evidenced by its ranking in the 2023 Scopus Quartiles, it holds a rank of Q2 in Biochemistry and Q3 in both Cell and Molecular Biology, placing it among the top tiers of scientific journals in these disciplines. The Journal of Cellular Biochemistry serves as a vital resource for researchers, professionals, and students alike, providing a platform for the dissemination of innovative ideas and findings that shape our understanding of cellular processes and biochemical pathways. Though it does not currently offer Open Access options, its robust peer-review process ensures that each publication meets the highest academic standards, thus solidifying its esteemed position in the landscape of biochemical research.

GENES & DEVELOPMENT

Bridging Breakthroughs in Genetics and Development
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 0890-9369Frequency: 24 issues/year

GENES & DEVELOPMENT, published by COLD SPRING HARBOR LAB PRESS, stands as a premier journal in the fields of Developmental Biology and Genetics, boasting a remarkable impact factor that reflects its prestigious position in the academic community—ranking Q1 in both disciplines as of 2023. Since its inception in 1987, this journal has been at the forefront of disseminating cutting-edge research, effectively bridging the gap between laboratory breakthroughs and their applications in health and disease. Researchers and professionals rely on GENES & DEVELOPMENT for its rigorous peer-review process and its commitment to promoting innovative studies that unravel the complexities of gene functions and developmental processes. With Scopus rankings placing it in the top percentile among its peers, this journal serves as a vital resource for students and established scientists alike, aspiring to expand their knowledge and contribute to the ever-evolving landscape of genetic and developmental research.

CYTOTECHNOLOGY

Cultivating Discovery: Inspiring New Horizons in Bioengineering and Biotechnology.
Publisher: SPRINGERISSN: 0920-9069Frequency: 6 issues/year

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

CELL BIOLOGY INTERNATIONAL

Exploring the Frontiers of Cellular Science
Publisher: WILEYISSN: 1065-6995Frequency: 12 issues/year

CELL BIOLOGY INTERNATIONAL is a prestigious academic journal dedicated to the rapidly evolving field of cell biology, publishing high-quality research aimed at understanding cellular processes and their implications in various biological contexts. Published by Wiley, this journal has established its relevance with an H-Index that reflects its robust citation impact and a commendable Scopus Rank of #111 out of 285 in the field of Biochemistry, Genetics, and Molecular Biology, positioning it in the 61st percentile. Although it operates under a traditional subscription model, its influential insights are crucial for researchers, professionals, and students alike who are seeking cutting-edge developments in cellular mechanisms and their applications in medicine. The journal spans contributions dating back to 1993, providing a rich archive of knowledge that continues to shape the discourse within the scientific community. With a strong category ranking of Q3 in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, CELL BIOLOGY INTERNATIONAL stands as a reliable platform for disseminating transformative science in the cellular domain.

Cell Death Discovery

Championing high-impact research in biomedical sciences.
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Cell Death Discovery, published by Springer Nature, is a distinguished open-access journal dedicated to advancing the field of cell death research. Since its inception in 2015, the journal has rapidly established itself as a premier platform for high-quality research, currently holding a remarkable position in the Q1 quartiles across multiple categories, including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, and Immunology. With an impact factor reflecting its significant contribution to the scientific community, Cell Death Discovery invites submissions that explore the molecular mechanisms of cell death and its implications across various biomedical fields. The journal's open-access model ensures that groundbreaking research is accessible to a global audience, facilitating collaboration and dissemination among researchers, professionals, and students alike. Located in the UK, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, the journal continues to support innovative scholarship and foster a deeper understanding of the processes behind cell viability, development, and disease.

FOLIA BIOLOGICA

Connecting Researchers to Transformative Ideas
Publisher: CHARLES UNIV PRAGUE, FIRST FACULTY MEDICINEISSN: 0015-5500Frequency: 6 issues/year

FOLIA BIOLOGICA, published by Charles University Prague, First Faculty of Medicine, is an esteemed academic journal that has been contributing to the fields of Biochemistry, Cell Biology, Developmental Biology, Genetics, Immunology, and Molecular Biology since its inception in 1961. With an ISSN of 0015-5500, this journal serves as a vital platform for researchers and professionals to disseminate their findings and advance knowledge within these disciplines. Despite its current Category Quartiles ranking in the lower tiers (Q3 and Q4), FOLIA BIOLOGICA continues to provide valued insights and foster scholarly dialogue, particularly in its paralleled fields. The journal is headquartered in Prague, Czech Republic, and operates without Open Access options, which emphasizes its focus on curated, peer-reviewed content essential for academicians and students. By bridging theoretical and practical knowledge, FOLIA BIOLOGICA remains committed to enriching the scientific community and serving as a cornerstone for future research innovations.

CELL BIOLOGY AND TOXICOLOGY

Pioneering Insights in Cellular Toxicity
Publisher: SPRINGERISSN: 0742-2091Frequency: 6 issues/year

CELL BIOLOGY AND TOXICOLOGY, published by SPRINGER, stands as a vital journal within the realms of cell biology and toxicology, boasting an impressive 2023 Q1 ranking in its fields, alongside robust Scopus rankings placing it in the top 11th percentile for Toxicology and the 22nd for Health, Toxicology and Mutagenesis. With an ISSN of 0742-2091 and an E-ISSN of 1573-6822, the journal has been a cornerstone of scientific discourse since its inception in 1984, and will continue to converge innovative research until 2024. The journal focuses on the interplay between cellular mechanisms and toxicological implications, making it an essential resource for researchers, healthcare professionals, and students keen on advancing their understanding of these critical areas. Although it does not offer open access, its high impact and prestigious standing ensure that its publications reach a wide audience dedicated to significant advancements in the life sciences.